Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/4452
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGitonga, Lawrence Kirimi-
dc.contributor.authorBoru, Waqo Gufu-
dc.contributor.authorKwena, Arthur M.-
dc.contributor.authorMaritim, Marybeth-
dc.contributor.authorWamicwe, Joyce-
dc.contributor.authorRansom, James-
dc.date.accessioned2021-05-19T07:00:36Z-
dc.date.available2021-05-19T07:00:36Z-
dc.date.issued2019-
dc.identifier.urihttps://doi.org/10.1186/s13104-019-4829-4-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/4452-
dc.description.abstractObjectives:The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We con-ducted cross-sectional study among HIV-positive patients with suspected CM at Mbagathi Hospital, Nairobi, April–July 2017.Results:Of 124 capillary blood and serum and 99 cerebrospinal fluid (CSF) samples, LFA and LA had a concurrence on serum of 94.4%, kappa (0.88), sensitivity (100%) and specificity (91%). LFA and LA on CSF, was 97.9%, kappa (0.96), sensitivity (100%) and specificity (96%). LFA and India ink was 96.9%, kappa (0.94), sensitivity (100%) and specificity (94.1%). On CSF culture, concurrence was 72.7%, kappa (0.43), sensitivity (100%) and specificity (64%) and of LFA on capillary blood, serum and CSF was 100% with kappa (1.00), sensitivity and specificity of 100%en_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.subjectPoint of care testing evaluationen_US
dc.subjectCryptococcus meningitisen_US
dc.titlePoint of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017en_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.